Canakinumab Antibody
Canakinumab (ACZ885) is a recombinant human monoclonal antibody that potently neutralizes IL-1β, exhibiting anti-inflammatory effects in both in vitro assays and in vivo models of autoimmune and cardiovascular diseases. Its application extends to research areas including gout, atherosclerosis, and cytokine-driven inflammation.
Product Specifications
Product Name Alternative
IL Receptor, IL-1β, ILReceptor, Ilaris, ACZ 885
Target
IL Receptor, Interleukin
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
2.74 mg/mL
Purity
98.30% (May vary between batches)
Molecular Weight
145.18 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RR208770L4 10 µg
Wbscr27 (Mettl27) (NM_001109499) Rat Tagged Lenti ORF Clone
Sign In for Pricing
View Details PA1793-HRP 100 µg/Vial
Anti-Apoptosis repressor with CARD/NOL3 Antibody Picoband®, HRP Conjugate
Sign In for Pricing
View Details 
CST 24433S 100 µL
Histone H2A.X (D17A3) XP® Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)
Sign In for Pricing
View Details